RECRUITING

Adaptive and Individualized AAC Phase II

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall objective of this study is to develop an Augmentative and Alternative Communication (AAC) system that is effective in delivering a person-centric communication device that will provide a versatile access method that can automatically learn and adapt to the user's physical abilities by creating a personalized, comprehensive keyboard interface for communication, not otherwise available to people in need of alternative communication.

Official Title

Adaptive and Individualized AAC Phase II

Quick Facts

Study Start:2024-12-03
Study Completion:2025-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06337188

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:6 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults or Children; age greater than or equal to 6 y.o.
  2. * Male or female
  3. * Able to (a) spell, (b) follow 2-3 step directions, (c) read 40 point text
  4. * Have complex communication needs representing a broad spectrum of developmental and acquired severe motor impairments resulting from high spinal cord injury (SCI), chronic Guillain-Barre syndrome, brain stem stroke, cerebral palsy (CP), locked-in syndrome, among others.
  5. * Requires the use of an alternative access strategy to communicate and/or use technology that has been clinically prescribed and manually optimized following current clinical standards.
  6. * Sufficient control and voluntary muscle activation on either the head, hand, or foot (on the basis of clinical evaluation by clinical collaborators at University of Nebraska Medical Center) to use the proposed wearable AAC system for the purpose of this study.
  7. * Sufficient stamina and developmental maturity (on the basis of clinical evaluation by clinical collaborators at University of Nebraska Medical Center) to attend to the approximately 1-2 hour protocols outlined in Aims 2 and 3 without excess fatigue or distraction.
  8. * Availability for at least 5 testing sessions over the study period.
  9. * No medical or safety restrictions of active head, hand, or foot movement (as determined by clinical collaborators at University of Nebraska Medical Center).
  10. * Clinical evidence of preserved cognition by a score of 0 or 1 on NIHSS Consciousness and Communication item.
  11. * Ability to voluntarily blink eyes or raise eyebrows on command (for head selection) or contract fingers/hand grasp (for hand selection) or rotate foot (for foot selection).
  12. * Able to provide written, informed consent or an accompanying communication partner or parent/guardian (for individuals under 18 y.o) to provide written, informed consent/assent to participate in the study.
  13. * Able to speak and follow directions in English.
  1. * Non-English speaker.
  2. * Inability to follow simple instructions in English.
  3. * Medical history of musculoskeletal conditions (arthritis, spondylosis, etc.) that causes pain on head, hand, or foot movement.
  4. * Restricted active or passive rotation of head and neck resulting from unstable vertebral, spinal cord, or nerve roots that places the subject at risk for execution of the protocol.
  5. * Medical history of cardiac or respiratory complications, or similar disorders that would severely reduce stamina and/or place the subject at risk for conducting the different motor activities.
  6. * Unable to provide informed assent/consent in English.

Contacts and Locations

Study Contact

Bhawna Shiwani, M.S.
CONTACT
5085458217
bshiwani@altecresearch.com
Joshua Kline, Ph.D.
CONTACT
5085458212
jkline@altecresearch.com

Principal Investigator

Gianluca De Luca, M.S.
PRINCIPAL_INVESTIGATOR
Altec Inc.

Study Locations (Sites)

University of Nebraska Medical Center
Omaha, Nebraska, 68198
United States

Collaborators and Investigators

Sponsor: Altec Inc.

  • Gianluca De Luca, M.S., PRINCIPAL_INVESTIGATOR, Altec Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-03
Study Completion Date2025-03-01

Study Record Updates

Study Start Date2024-12-03
Study Completion Date2025-03-01

Terms related to this study

Additional Relevant MeSH Terms

  • Communication Disorders